Neonatal Hypoxic Ischemic Encephalopathy

4

Review clinical trials related to Neonatal Hypoxic Ischemic Encephalopathy. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Neonatal Brain Ultrasound With CEUS and Elastography

The aim of our study is to investigate changes of brain perfusion and elasticity in neonates during the time that a neonate is adapting to live outside the womb and during diseases that are suspected to affect neonatal brain perfusion. We use contrast enhanced ultrasound (sulphur hexafluoride) and ultrasound-assisted elastography to evaluate the state of brain perfusion. We will study neonates recruited from the Neonatal Units of Turku University Hospital.

Participants needed: 100
Trial details
Phase: Phase 3Age: 1-6Biological sex: AllType: InterventionalSponsor: Turku University HospitalUpdated: Jan 15, 2026Locations: 1
Eligibility criteria

Babies less than 7 months treated at the neonatal units of Turku University hosp...

Pre-known genetic disease [+7]

Status: Recruiting

Feasibility and Safety of Intranasally Administered Breast Milk in HIE

This is a prospective intervention single center study to evaluate the feasibility and safety of intranasal breast milk in hypoxic-ischaemic encephalopathic neonates receiving therapeutic hypothermia.

Participants needed: 10
Trial details
Phase: Early Phase 1Age: Up to 48Biological sex: AllType: InterventionalSponsor: Semmelweis UniversityUpdated: May 22, 2025Locations: 1
Eligibility criteria

Moderate or severe hypoxic- ischaemic encephalopathy, receiving therapeutic hypo... [+4]

Congenital malformation [+5]

Status: Recruiting

Intranasal Breast Milk Therapy in HIE

This is an open-label prospective single-center randomized controlled trial to evaluate the effect of intranasal breast milk in hypoxic-ischemic encephalopathic neonates receiving therapeutic hypothermia on long term neurodevelopmental outcome compared to standard care.

Participants needed: 80
Trial details
Phase: Early Phase 1Age: Up to 48Biological sex: AllType: InterventionalSponsor: Semmelweis UniversityUpdated: Dec 24, 2024Locations: 1
Eligibility criteria

Moderate or severe hypoxic- ischemic encephalopathy, receiving therapeutic hypot... [+2]

Congenital malformation [+5]

Status: Not yet recruiting

Erythropoietin in HIE Neonate

this study is aim to delineate the role of erythropoietin in improving neonatal hypoxic ischemic encephalopathy the study is conducted to answer the question : is erythropoietin will improve neonatal hypoxic ischemic encephalopathy?

Participants needed: 3
Trial details
Phase: Early Phase 1Age: 1-1Biological sex: AllType: InterventionalSponsor: Assiut UniversityUpdated: Sep 19, 2024Locations: 1
Eligibility criteria

neonates who more than 1 month [+1]